FDA Approves First Generic Single-Dose Flu Medication

The U.S. Food and Drug Administration (FDA) has granted approval for the first generic version of a single-dose influenza treatment. Manufactured by Genetech, Inc., this medication is approved for patients aged five and older, previously known by the brand name Xofluza. This regulatory decision is anticipated to foster greater market competition and potentially reduce costs for consumers.